Capricor Therapeutics, Inc. (CAPR) Earning

NASDAQ Currency in USD Disclaimer

$14.15

north_east $1.08 (8.26%)
Day's range
$12.67
Day's range
$14.16

Capricor Therapeutics, Inc. Analyst EPS Estimates

Quarter Number of Estimates Low Estimate High Estimate Average Estimate
Q1 2024 1 -$0.13 -$0.10 -$0.11
Q2 2024 1 -$0.39 -$0.32 -$0.36
Q3 2024 1 -$0.39 -$0.32 -$0.36
Q4 2024 4 -$0.20 -$0.16 -$0.18
Q1 2025 2 -$0.40 -$0.31 -$0.36
Q2 2025 1 -$0.43 -$0.35 -$0.39
Q3 2025 1 -$0.43 -$0.35 -$0.39
Q4 2025 1 -$0.35 -$0.29 -$0.32

Capricor Therapeutics, Inc. Earnings Date And Information

Capricor Therapeutics, Inc. last posted its earnings results on Wednesday, November 13th, 2024. The company reported $-0.38 earnings per share for the quarter, missing analysts' consensus estimates of $-0.34 by $0.04. The company had revenue of 2.26 M for the quarter and had revenue of 25.18 M for the year. Capricor Therapeutics, Inc. has generated $-1 earnings per share over the last year ($-0.83 diluted earnings per share) and currently has a price-to-earnings ratio of -13.71. Capricor Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.

Capricor Therapeutics, Inc. Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
11/14/2024 Q3 2024 -$0.38 $4.28 M $2.26 M
08/08/2024 Q2 2024 -$0.35 $4.58 M $3.97 M
05/14/2024 Q1 2024 -$0.31 $4.91 M
03/11/2024 Q4 2023 -$0.02 $12.09 M
11/14/2023 Q3 2023 -$0.27 -$0.25 0.02 $3.15 M $6.19 M
08/08/2023 Q2 2023 -$0.29 $3.00 M $3.92 M
05/12/2023 Q1 2023 $16.19 $2.99 M
03/17/2023 Q4 2022 -$0.31 $957,351
11/10/2022 Q3 2022 -$0.28 -$0.26 0.02 $420,000 $1.59 M
08/11/2022 Q2 2022 -$0.28 $390,000 $0
05/11/2022 Q1 2022 -$0.32 $0
03/10/2022 Q4 2021 -$0.26 $244.65 M
11/10/2021 Q3 2021 -$0.17 $210,000 $0
08/13/2021 Q2 2021 -$0.21 $210,000 $204,082
05/14/2021 Q1 2021 -$0.23 $40,816
03/15/2021 Q4 2020 -$0.21 $57,830
11/13/2020 Q3 2020 -$0.20 $210,000 $16,863
08/10/2020 Q2 2020 -$0.23 $210,000 $49,864
05/15/2020 Q1 2020 -$0.30 $185,693
03/27/2020 Q4 2019 -$0.34 $222,100
 

Capricor Therapeutics, Inc. Earnings: FAQ's

When is Capricor Therapeutics, Inc.'s earnings date?

Capricor Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates.

How can I listen to Capricor Therapeutics, Inc.'s earnings conference call?

The conference call for Capricor Therapeutics, Inc.'s latest earnings report can be listened to online.

How can I read Capricor Therapeutics, Inc.'s conference call transcript?

The conference call transcript for Capricor Therapeutics, Inc.'s latest earnings report can be read online.

How much revenue does Capricor Therapeutics, Inc. generate each year?

Capricor Therapeutics, Inc. (:CAPR) has a recorded annual revenue of $25.18 M.

How much profit does Capricor Therapeutics, Inc. generate each year?

Capricor Therapeutics, Inc. (:CAPR) has a recorded net income of $25.18 M. Capricor Therapeutics, Inc. has generated $-0.83 earnings per share over the last four quarters.

What is Capricor Therapeutics, Inc.'s price-to-earnings ratio?

Capricor Therapeutics, Inc. (:CAPR) has a price-to-earnings ratio of -13.71 and price/earnings-to-growth ratio is 0.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED